HighVista Strategies LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$2,065,828
-21.9%
39,804
-9.7%
0.96%
-21.0%
Q2 2023$2,643,876
+305.3%
44,094
+234.2%
1.21%
+127.9%
Q1 2023$652,311
-13.4%
13,1940.0%0.53%
+18.8%
Q4 2022$752,982
-3.3%
13,194
-20.5%
0.45%
+0.4%
Q3 2022$779,00016,5880.44%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders